In order to determine whether more physiologically-relevant agonists could induce NET production in neutrophils from patients with inflammatory disease, we screened a range of agonists [including TLR- and FcγR-agonists and RA synovial fluid (SF)] using RA neutrophils (n = 3). This evidence concerns the gene FCGR2A and rheumatoid arthritis.